Through purpose-driven science, empowering medicines, and transformative advocacy we seek to improve the lives of millions.
Our areas of focus
Endometriosis
An estimated 7.5 million premenopausal women in the U.S. have endometriosis.
Prostate Cancer
Approximately 3 million men alive today in the U.S. have been diagnosed with prostate cancer.
MYOVANT STORIES
A video series on how men with prostate cancer find strength in community.
Watch videos »
Thomasine’s journey through uterine fibroids started with pain but led to empowerment.
Read article »
PURPOSE-DRIVEN SCIENCE
Myovant is developing innovative medicines that hold promise to improve people’s lives.
TRANSFORMATIVE ADVOCACY
We’re partnering with cross-sector coalitions to fight stigma, raise awareness, and empower people with information.
Social Media
News
View more newsSTATEMENT
30 Jun 2022
Myovant Statement: U.S. Supreme Court Ruling in Dobbs v. Jackson Women’s Health Organization
Now FDA Approved for a second indication. You can learn more about MYFEMBREE by visiting the product website and downloading the full U.S. Prescribing Information including BOXED WARNING and Patient Information.
For U.S. Audiences Only.